BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 21425440)

  • 1. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity.
    Janesick A; Blumberg B
    Birth Defects Res C Embryo Today; 2011 Mar; 93(1):34-50. PubMed ID: 21425440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesogens, stem cells and the developmental programming of obesity.
    Janesick A; Blumberg B
    Int J Androl; 2012 Jun; 35(3):437-48. PubMed ID: 22372658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesogens: an emerging threat to public health.
    Janesick AS; Blumberg B
    Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine Disruptors and Obesity.
    Darbre PD
    Curr Obes Rep; 2017 Mar; 6(1):18-27. PubMed ID: 28205155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal Exposure to Endocrine Disruptors and Reprogramming of Adipogenesis: An Early-Life Risk Factor for Childhood Obesity.
    Shafei AE; Nabih ES; Shehata KA; Abd Elfatah ESM; Sanad ABA; Marey MY; Hammouda AAMA; Mohammed MMM; Mostafa R; Ali MA
    Child Obes; 2018 Jan; 14(1):18-25. PubMed ID: 29019419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minireview: PPARγ as the target of obesogens.
    Janesick A; Blumberg B
    J Steroid Biochem Mol Biol; 2011 Oct; 127(1-2):4-8. PubMed ID: 21251979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine disruptors and obesity.
    Heindel JJ; Newbold R; Schug TT
    Nat Rev Endocrinol; 2015 Nov; 11(11):653-61. PubMed ID: 26391979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
    Grün F; Blumberg B
    Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenerational inheritance of prenatal obesogen exposure.
    Janesick AS; Shioda T; Blumberg B
    Mol Cell Endocrinol; 2014 Dec; 398(1-2):31-5. PubMed ID: 25218215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
    Stel J; Legler J
    Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocrine disruptor 4-nonylphenol promotes adipocyte differentiation and induces obesity in mice.
    Hao CJ; Cheng XJ; Xia HF; Ma X
    Cell Physiol Biochem; 2012; 30(2):382-94. PubMed ID: 22739433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocrine disruptor mono-(2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice.
    Hao C; Cheng X; Xia H; Ma X
    Biosci Rep; 2012 Dec; 32(6):619-29. PubMed ID: 22953781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesogens, stem cells and the maternal programming of obesity.
    Blumberg B
    J Dev Orig Health Dis; 2011 Feb; 2(1):3-8. PubMed ID: 26401242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesogens.
    Grün F
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):453-9. PubMed ID: 20689419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity II: Establishing causal links between chemical exposures and obesity.
    Heindel JJ; Howard S; Agay-Shay K; Arrebola JP; Audouze K; Babin PJ; Barouki R; Bansal A; Blanc E; Cave MC; Chatterjee S; Chevalier N; Choudhury M; Collier D; Connolly L; Coumoul X; Garruti G; Gilbertson M; Hoepner LA; Holloway AC; Howell G; Kassotis CD; Kay MK; Kim MJ; Lagadic-Gossmann D; Langouet S; Legrand A; Li Z; Le Mentec H; Lind L; Monica Lind P; Lustig RH; Martin-Chouly C; Munic Kos V; Podechard N; Roepke TA; Sargis RM; Starling A; Tomlinson CR; Touma C; Vondracek J; Vom Saal F; Blumberg B
    Biochem Pharmacol; 2022 May; 199():115015. PubMed ID: 35395240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot-Specific Analysis of Human Adipose Cells and Their Responses to Bisphenol S.
    Peshdary V; Styles G; Gagné R; Yauk CL; Sorisky A; Atlas E
    Endocrinology; 2020 Jun; 161(6):. PubMed ID: 32170302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BPA, BPAF and TMBPF Alter Adipogenesis and Fat Accumulation in Human Mesenchymal Stem Cells, with Implications for Obesity.
    Cohen IC; Cohenour ER; Harnett KG; Schuh SM
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid X Receptor Activation Alters the Chromatin Landscape To Commit Mesenchymal Stem Cells to the Adipose Lineage.
    Shoucri BM; Martinez ES; Abreo TJ; Hung VT; Moosova Z; Shioda T; Blumberg B
    Endocrinology; 2017 Oct; 158(10):3109-3125. PubMed ID: 28977589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenerational effects of obesogens.
    Lee MK; Blumberg B
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3(Suppl 3):44-57. PubMed ID: 30801972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental Obesogens: Mechanisms and Controversies.
    Heindel JJ; Blumberg B
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():89-106. PubMed ID: 30044726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.